Shares in Nanexa soar on €1bn Novo Nordisk deal

The Novo Nordisk, the manufacturer of Ozempic and Wegovy, has signed an exclusive licence to use Nanexa’s proprietary drug delivery technology PharmaShell platform for certain therapeutic peptide drugs for various indications, including obesity and type 2 diabetes.Under the terms of the deal, Novo…